Vis enkel innførsel

dc.contributor.authorWilkens, Philipen_US
dc.contributor.authorStorheim, Kjerstien_US
dc.contributor.authorScheel, Ingeren_US
dc.contributor.authorBerg, Lindaen_US
dc.contributor.authorEspeland, Ansgaren_US
dc.date.accessioned2013-09-17T14:20:49Z
dc.date.available2013-09-17T14:20:49Z
dc.date.issued2012-08-17eng
dc.PublishedJournal of Negative Results in BioMedicine 11(1):13eng
dc.identifier.issn1477-5751
dc.identifier.urihttps://hdl.handle.net/1956/7212
dc.description.abstractBackground: The underlying pathology and natural course of Modic changes (MC) in the vertebral body marrow and high intensity zones (HIZs) in the annulus fibrosus is not completely clarified. These findings on magnetic resonance imaging (MRI) have initiated different treatments with little or unclear effect. In a randomized trial (n = 250), glucosamine sulfate (GS) had no effect on low back pain related disability. GS could still have an effect on MC and HIZ. In this sub-study, 45 patients from the trial who had MC and/or HIZ at pre-treatment underwent follow-up MRI. The aim was to examine the course of MC and HIZ and to compare this course between groups treated with 6-month intake of oral GS versus placebo. Results: Of 141 pre-treatment MC in 42 (of 45) patients, 29 (20.6%) MC in 18 patients had altered type and 14 MC in 9 patients had altered size (decreased for 1 MC) 6-18 months later: odds ratio (OR) for type vs. size alterations 4.0; 95% confidence interval (CI) 1.2-17.7. No MC resolved. HIZ vanished from 3 of 23 discs in 3 of 21 patients with pre-treatment HIZ. Ten new MC (all type I or I/II) occurred in 8 patients and 2 new HIZs in 2 patients. The GS group (n = 19) and placebo group (n = 26) did not differ in proportions of MC with decreased (OR 1.6; 95% CI 0.4-6.1) or increased type I dominance at follow-up (OR placebo:GS 2.4; 95% CI 0.6-9.7), or with increased size (OR 1.0; 95% CI 0.2-4.7). HIZ vanished from 1 of 8 discs in 1 of 8 patients in the GS group vs. 2 of 15 discs in 2 of 13 patients in the placebo group (OR 0.8; 95% CI 0.02-12.2). Conclusions: In this sub-group analysis of a placebo-controlled trial, the effect of GS on MC and HIZs was no different from the effect of the placebo intervention. MC and HIZs remained mostly unchanged during the 6-18 months study period. Some short term changes did occur and MC more often altered type than size.en_US
dc.language.isoengeng
dc.publisherBioMed Centraleng
dc.rightsAttribution CC BYeng
dc.rights.urihttp://creativecommons.org/licenses/by/2.0/eng
dc.subjectGlucosamine sulfateeng
dc.subjectHigh intensity zoneeng
dc.subjectLow back paineng
dc.subjectLumbar spineeng
dc.subjectMagnetic resonance imagingeng
dc.subjectModic changeseng
dc.subjectRandomized trialeng
dc.subjectTreatment effecteng
dc.titleNo effect of 6-month intake of glucosamine sulfate on Modic changes or high intensity zones in the lumbar spine: sub-group analysis of a randomized controlled trialen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2013-08-23T09:09:20Z
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2012 Wilkens et al.; licensee BioMed Central Ltd.
dc.rights.holderPhilip Wilkens et al.; licensee BioMed Central Ltd.
dc.identifier.doihttps://doi.org/10.1186/1477-5751-11-13
dc.identifier.cristin1000973
dc.source.journalJournal of Negative Results in BioMedicine
dc.source.4011
dc.source.141
dc.source.pagenumber13-


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution CC BY
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution CC BY